bio-based chemicals

Photo
03.06.2024 • News

Neste, Marubeni and Resonac to Collaborate on Renewable Chemicals in Japan

Neste, Marubeni and Resonac have agreed to cooperate on the production of renewable olefins and derivatives. The cooperation involves Neste RE, a Neste-produced renewable raw material, being used to manufacture products at leading Japanese chemical company Resonac’s Oita Complex in Japan. Marubeni, a major Japanese general trading and investment conglomerate, will coordinate all logistical arrangements from Neste to Resonac, the partners said.

Photo
18.03.2024 • NewsStrategy

Revolutionizing Green Chemical Production with Ultrasound

Biorefining allows low-carbon feedstocks – such as lignocellulosic biomass – to be processed into intermediate chemicals that can be made into renewable plastics for the automotive industry. Sonichem has developed a breakthrough biorefinery technique that uses ultrasonic energy alongside mild organic acids to fractionate softwood sawdust into hemicellulose sugars, microcrystalline cellulose and high-quality lignin.

Photo
02.11.2023 • News

DMC Opens New Lab in North Carolina

DMC Biotechnologies announced a new 880 square meter (9,500 square foot) metabolic engineering and fermentation facility in North Carolina, to support a team of scientists advancing DMC products and active collaborations.

Photo
16.11.2022 • News

Sinarmas CEPSA Expands Bio-based Chemicals

Sinarmas CEPSA, a 50:50 joint venture between Spanish CEPSA and Indonesian conglomerate Sinar Mas, has signed a Memorandum of Understanding (MoU) with Singaporean palm oil producer Golden Agri-Resources – a subsidiary of Sinar Mas – to expand bio-based chemicals production.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.